Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Disease Staging

Name: Tumor Board: Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum
Start: 2025-09-07T18:30:00+02:00
End: 2025-09-07T19:30:00+02:00

April 12, 2023

IASLC Staging Project Finalizing Recommendations for 9th Edition of TNM Classification System

By

Erin Jungmeyer

Disease Staging, Evolving Standards of Care, Society News

In a recent interview, Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura provides an update on efforts to further refine the system.
April 12, 2023

Staging Experts Offer Insights on Challenges of Nodal Classification

By

David Ball, MBBS, MD, FRANZCR, FACR (Hon), et al.

Disease Staging, Evolving Standards of Care

Adding to the discussion, Drs. David Ball, Daniel Steinfort, and Susan Harden propose alternative approaches for the complex task of improving nodal staging.
September 6, 2020

Lung Cancer Diagnosis and Staging During COVID-19

By

Disease Staging

Re-establishing protocols and systems for accurate and timely diagnosis and staging despite fears and high volume is critical to patient survival.

Disease Staging

IASLC Staging Project Finalizing Recommendations for 9th Edition of TNM Classification System

Staging Experts Offer Insights on Challenges of Nodal Classification

Lung Cancer Diagnosis and Staging During COVID-19

IS03: Satellite EBAC/CME Symposium by Answers in CME: Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes

Tumor Board: Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum

COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC